Long-term safety and tolerability of entecavir in patients with chronic hepatitis B in the rollover study ETV-901-Reference-Cited by-同舟云学术

Long-term safety and tolerability of entecavir in patients with chronic hepatitis B in the rollover study ETV-901

Published:2012-01-11 Issue:3 Volume:11 Page:361-368
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Manns Michael P,Akarca Ulus S,Chang Ting-Tsung,Sievert William,Yoon Seung Kew,Tsai Naoky,Min Albert,Pangerl Andreas,Beebe Suzanne,Yu Miao,Wongcharatrawee Suchat

Publisher

Informa Healthcare

Subject

Pharmacology (medical),General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/14740338.2012.653340

Reference39 articles.

1. EASL Clinical Practice Guidelines: Management of chronic hepatitis B

2. Chronic hepatitis B: Update 2009

3. Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B

4. Prevalence and Clinical Correlates of YMDD Variants during Lamivudine Therapy for Patients with Chronic Hepatitis B

5. Side effects of long-term oral antiviral therapy for hepatitis B

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Research on LLV Patients with Chronic Hepatitis B;Advances in Clinical Medicine;2023

2. Quantitative analysis of binary mixtures of entecavir using solid-state analytical techniques with chemometric methods;Arabian Journal of Chemistry;2021-10

3. Transaminase Elevations during Treatment of Chronic Hepatitis B Infection: Safety Considerations and Role in Achieving Functional Cure;Viruses;2021-04-23

4. Nucleos(t)ide Therapy and Long-Term Outcomes;Hepatitis B Virus and Liver Disease;2021

5. Subclinical proximal tubulopathy in hepatitis B: The roles of nucleot(s)ide analogue treatment and the hepatitis B virus;World Journal of Hepatology;2020-12-27